Total Payments
$3,848
2024 Payments
$1,053
Companies
9
Transactions
127
Medicare Patients
1,741
Medicare Billing
$241,842
Payment Breakdown by Category
Food & Beverage$3,504 (91.1%)
Consulting$344.17 (8.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,504 | 126 | 91.1% |
| Consulting Fee | $344.17 | 1 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,299 | 66 | $0 (2024) |
| Amgen Inc. | $842.43 | 10 | $0 (2024) |
| Allergan, Inc. | $560.44 | 42 | $0 (2020) |
| Baxter Healthcare | $344.17 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $249.88 | 2 | $0 (2023) |
| Respiratory Technologies, Inc. | $171.09 | 3 | $0 (2017) |
| Mallinckrodt Hospital Products Inc. | $148.83 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $116.67 | 1 | $0 (2018) |
| Dexcom, Inc. | $116.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,053 | 22 | ABBVIE INC. ($361.96) |
| 2023 | $1,292 | 30 | Amgen Inc. ($495.48) |
| 2022 | $243.81 | 15 | ABBVIE INC. ($243.81) |
| 2021 | $411.39 | 14 | AbbVie Inc. ($286.51) |
| 2020 | $114.86 | 14 | Allergan, Inc. ($114.86) |
| 2019 | $108.56 | 14 | Allergan Inc. ($108.56) |
| 2018 | $312.95 | 13 | Allergan Inc. ($196.28) |
| 2017 | $311.83 | 5 | Respiratory Technologies, Inc. ($171.09) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/25/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/22/2024 | Baxter Healthcare | Fluid Systems - Access Systems (Biological) | Consulting Fee | Cash or cash equivalent | $344.17 | General |
| Category: Fluid Systems | ||||||
| 09/27/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/10/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/01/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/04/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/14/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/23/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/26/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/29/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/15/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $99.11 | General |
| Category: Inflammation | ||||||
| 03/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $99.76 | General |
| Category: Inflammation | ||||||
| 02/22/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/14/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Inflammation | ||||||
| 01/31/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $116.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: Inflammation | ||||||
| 01/25/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/06/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/15/2023 | AbbVie Inc. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/06/2023 | AbbVie Inc. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/29/2023 | AbbVie Inc. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 769 | 1,064 | $272,750 | $116,271 |
| 2022 | 4 | 152 | 248 | $116,452 | $20,479 |
| 2021 | 6 | 357 | 542 | $238,032 | $44,132 |
| 2020 | 7 | 463 | 832 | $329,177 | $60,960 |
Total Patients
1,741
Total Services
2,686
Medicare Billing
$241,842
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 277 | 396 | $99,000 | $46,349 | 46.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 232 | 267 | $93,550 | $37,183 | 39.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 260 | 401 | $80,200 | $32,739 | 40.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 73 | 169 | $56,539 | $8,994 | 15.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $26,600 | $5,689 | 21.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $24,353 | $4,646 | 19.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $8,960 | $1,149 | 12.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 126 | 293 | $91,500 | $16,084 | 17.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 82 | 82 | $62,042 | $12,077 | 19.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 59 | 59 | $41,697 | $8,879 | 21.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 42 | 42 | $24,006 | $3,336 | 13.9% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 32 | 50 | $13,923 | $2,764 | 19.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 16 | 16 | $4,864 | $992.28 | 20.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 180 | 495 | $153,095 | $27,651 | 18.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 79 | 83 | $61,248 | $12,560 | 20.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 82 | 84 | $48,720 | $6,746 | 13.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 45 | 46 | $31,050 | $6,714 | 21.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 44 | 91 | $24,570 | $4,995 | 20.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 22 | 22 | $6,514 | $1,400 | 21.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $3,980 | $894.12 | 22.5% |
About Dr. Syed Ali, M.D
Dr. Syed Ali, M.D is a Hospitalist healthcare provider based in Appleton, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023207586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Ali, M.D has received a total of $3,848 in payments from pharmaceutical and medical device companies, with $1,053 received in 2024. These payments were reported across 127 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,504).
As a Medicare-enrolled provider, Ali has provided services to 1,741 Medicare beneficiaries, totaling 2,686 services with total Medicare billing of $241,842. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Appleton, WI
- Active Since 10/22/2007
- Last Updated 08/20/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023207586
Products in Payments
- DALVANCE (Drug) $998.17
- TAVNEOS (Drug) $842.43
- AVYCAZ (Drug) $401.81
- Fluid Systems - Access Systems (Biological) $344.17
- TEFLARO (Drug) $335.23
- FARXIGA (Drug) $249.88
- TERLIVAZ (Drug) $148.83
- VRAYLAR (Drug) $123.78
- ELIQUIS (Drug) $116.67
- DEXCOM G7 GSS (161) (Medical Supply) $116.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Appleton
Hussam Sawass, M.d, M.D
Hospitalist — Payments: $1,104
Hospitalist $1,104
Musa Khan, Md, MD
Hospitalist — Payments: $599.66
Hospitalist $599.66
Sarah Saleemi
Hospitalist — Payments: $300.85
Hospitalist $300.85
Idiris Esse, Md, MD
Hospitalist — Payments: $122.06
Hospitalist $122.06
Lulseged Zenebe, Md, MD
Hospitalist — Payments: $121.95
Hospitalist $121.95
Eric Winkel, Do, DO
Hospitalist — Payments: $59.68
Hospitalist $59.68